Report cover image

Plasmid DNA Manufacturing Market Size, Industry Share and Global Forecast 2024 - 2032

Publisher Acumen Research and Consulting
Published Dec 01, 2024
Length 250 Pages
SKU # ACRC19863207

Description

The Global Plasmid DNA Manufacturing Market Size accounted for USD 1.9 Billion in 2023 and is estimated to achieve a market size of USD 10.5 Billion by 2032 growing at a CAGR of 20.9% from 2024 to 2032.

The plasmid DNA manufacturing market is experiencing rapid growth, driven by the increasing demand for gene therapies, vaccine development, and advancements in biotechnology research. Plasmid DNA (pDNA) is a small, circular piece of DNA that is commonly used in genetic research, biotechnology, and the production of therapeutic proteins and vaccines. Due to its versatility, stability, and ability to be replicated in bacterial cells, plasmid DNA plays a vital role in gene therapy applications, vaccine development, and the production of recombinant proteins. The market for plasmid DNA manufacturing is expected to expand significantly over the coming years as the demand for advanced biopharmaceuticals and personalized medicine grows, with an emphasis on cutting-edge gene therapies and DNA-based vaccines.

Plasmid DNA manufacturing involves the extraction, purification, and production of plasmid DNA from bacterial sources, which is then used in a variety of applications, including gene delivery systems, research on genetic disorders, vaccine production, and cell-based therapies. The key factors driving the growth of the plasmid DNA manufacturing market include the increasing adoption of gene therapies for the treatment of genetic diseases, the rising focus on cell and gene therapies in oncology, and the accelerating development of DNA-based vaccines, particularly in response to the COVID-19 pandemic.

Plasmid DNA Manufacturing Market Segmentation

The worldwide market for plasmid DNA manufacturing is split based on grade, disease, development phase, application, and geography.

Plasmid DNA Manufacturing Market By Grade

R&D Grade
Viral Vector Development
Lentivirus
AAV
Retrovirus
Adenovirus
Others
Antibody Development
mRNA Development
DNA Vaccine Development
Others
GMP Grade

Plasmid DNA Manufacturing D Market By Disease

Infectious Disease
Cancer
Genetic Disorder

Plasmid DNA Manufacturing Market By Development Phase

Clinical Therapeutics
Pre-Clinical Therapeutics
Marketed Therapeutics

Plasmid DNA Manufacturing Market By Application

DNA Vaccines
Cell & Gene Therapy
Immunotherapy
Others

Plasmid DNA Manufacturing Market Regional Outlook

North America
U.S.
Canada

Europe
U.K.
Germany
France
Spain
Rest of Europe

Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific

Latin America
Brazil
Mexico
Rest of Latin America

The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

Plasmid DNA Manufacturing Market Players

Some of the top plasmid DNA manufacturing market companies offered in our report includes Aldevron, Akron Biotech, VGXI, Inc., Nature Technology Corporation, Plasmidfactory GmbH, Cobra Biologics & Pharmaceutical Services, Vigene Biosciences, Luminous Biosciences, JAFRAL Ltd., and Delphi Genetics.

How Acumen Research and Consulting Reserch Study of helps clients in their decision making:

Creating strategies for new product development
Supporting & Adjust Investment/business decisions
Benchmark and judge own competitiveness
Aiding in the business planning process
Serving as a credible, independent check on company internal forecasts
Supporting acquisition strategies

Table of Contents

250 Pages
CHAPTER 1. Industry Overview of Plasmid DNA Manufacturing Market
1.1. Definition and Scope
1.2. Summary
CHAPTER 2. Research Approach
2.1. Methodology
2.2. Data Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.2. Restraints and Challenges
3.3. Growth Opportunities
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Plasmid DNA Manufacturing Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Plasmid DNA Manufacturing Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2023
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Plasmid DNA Manufacturing Market By Grade
5.1. Introduction
5.2. Plasmid DNA Manufacturing Revenue By Grade
5.2.1. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast, By Grade, 2020-2032
5.2.2. R&D Grade
5.2.2.1. R&D Grade Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2. Viral Vector Development
5.2.2.2.1. Viral Vector Development Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2.2. Lentivirus
5.2.2.2.2.1. Lentivirus Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2.3. AAV
5.2.2.2.3.1. AAV Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2.4. Retrovirus
5.2.2.2.4.1. Retrovirus Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2.5. Adenovirus
5.2.2.2.5.1. Adenovirus Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2.6. Others
5.2.2.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.3. Antibody Development
5.2.2.3.1. Antibody Development Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.4. mRNA Development
5.2.2.4.1. mRNA Development Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.5. DNA Vaccine Development
5.2.2.5.1. DNA Vaccine Development Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.6. Others
5.2.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. GMP Grade
5.2.3.1. GMP Grade Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Plasmid DNA Manufacturing Market By Disease
6.1. Introduction
6.2. Plasmid DNA Manufacturing Revenue By Disease
6.2.1. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast, By Disease, 2020-2032
6.2.2. Infectious Disease
6.2.2.1. Infectious Disease Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Cancer
6.2.3.1. Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Genetic Disorder
6.2.4.1. Genetic Disorder Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Plasmid DNA Manufacturing Market By Development Phase
7.1. Introduction
7.2. Plasmid DNA Manufacturing Revenue By Development Phase
7.2.1. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast, By Development Phase, 2020-2032
7.2.2. Clinical Therapeutics
7.2.2.1. Clinical Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Pre-Clinical Therapeutics
7.2.3.1. Pre-Clinical Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Marketed Therapeutics
7.2.4.1. Marketed Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. Plasmid DNA Manufacturing Market By Application
8.1. Introduction
8.2. Plasmid DNA Manufacturing Revenue By Application
8.2.1. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast, By Application, 2020-2032
8.2.2. DNA Vaccines
8.2.2.1. DNA Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.3. Cell & Gene Therapy
8.2.3.1. Cell & Gene Therapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.4. Immunotherapy
8.2.4.1. Immunotherapy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.5. Others
8.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Plasmid DNA Manufacturing Market By Country
9.1. North America Plasmid DNA Manufacturing Market Overview
9.2. U.S.
9.2.1. U.S. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
9.2.2. U.S. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
9.2.3. U.S. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
9.2.4. U.S. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
9.3. Canada
9.3.1. Canada Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
9.3.2. Canada Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
9.3.3. Canada Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
9.3.4. Canada Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Plasmid DNA Manufacturing Market By Country
10.1. Europe Plasmid DNA Manufacturing Market Overview
10.2. U.K.
10.2.1. U.K. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
10.2.2. U.K. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
10.2.3. U.K. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
10.2.4. U.K. Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
10.3. Germany
10.3.1. Germany Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
10.3.2. Germany Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
10.3.3. Germany Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
10.3.4. Germany Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
10.4. France
10.4.1. France Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
10.4.2. France Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
10.4.3. France Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
10.4.4. France Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
10.5. Spain
10.5.1. Spain Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
10.5.2. Spain Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
10.5.3. Spain Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
10.5.4. Spain Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
10.6.2. Rest of Europe Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
10.6.3. Rest of Europe Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
10.6.4. Rest of Europe Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Plasmid DNA Manufacturing Market By Country
11.1. Asia Pacific Plasmid DNA Manufacturing Market Overview
11.2. China
11.2.1. China Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
11.2.2. China Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
11.2.3. China Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
11.2.4. China Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
11.3. Japan
11.3.1. Japan Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
11.3.2. Japan Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
11.3.3. Japan Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
11.3.4. Japan Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
11.4. India
11.4.1. India Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
11.4.2. India Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
11.4.3. India Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
11.4.4. India Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
11.5. Australia
11.5.1. Australia Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
11.5.2. Australia Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
11.5.3. Australia Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
11.5.4. Australia Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
11.6. South Korea
11.6.1. South Korea Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
11.6.2. South Korea Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
11.6.3. South Korea Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
11.6.4. South Korea Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
11.7.2. Rest of Asia-Pacific Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
11.7.3. Rest of Asia-Pacific Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
11.7.4. Rest of Asia-Pacific Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Plasmid DNA Manufacturing Market By Country
12.1. Latin America Plasmid DNA Manufacturing Market Overview
12.2. Brazil
12.2.1. Brazil Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
12.2.2. Brazil Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
12.2.3. Brazil Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
12.2.4. Brazil Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
12.3. Mexico
12.3.1. Mexico Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
12.3.2. Mexico Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
12.3.3. Mexico Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
12.3.4. Mexico Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
12.4.2. Rest of Latin America Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
12.4.3. Rest of Latin America Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
12.4.4. Rest of Latin America Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Plasmid DNA Manufacturing Market By Country
13.1. Middle East & Africa Plasmid DNA Manufacturing Market Overview
13.2. GCC
13.2.1. GCC Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
13.2.2. GCC Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
13.2.3. GCC Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
13.2.4. GCC Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
13.3. South Africa
13.3.1. South Africa Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
13.3.2. South Africa Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
13.3.3. South Africa Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
13.3.4. South Africa Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Disease, 2020-2032
13.4.2. Rest of Middle East & Africa Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Grade, 2020-2032
13.4.3. Rest of Middle East & Africa Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Development Phase, 2020-2032
13.4.4. Rest of Middle East & Africa Plasmid DNA Manufacturing Revenue (USD Million) and Forecast By Application, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Plasmid DNA Manufacturing Market
14.1. Plasmid DNA Manufacturing Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Plasmid DNA Manufacturing Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Aldevron
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Million), 2023
15.1.3.2. Aldevron 2023 Plasmid DNA Manufacturing Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Akron Biotech
15.3. VGXI, Inc.
15.4. Nature Technology Corporation
15.5. Plasmidfactory GmbH
15.6. Cobra Biologics & Pharmaceutical Services
15.7. Vigene Biosciences
15.8. Luminous Biosciences
15.9. JAFRAL Ltd.
15.10. Delphi Genetics

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us